Putting Science to Work
  • Kiran Mazumdar Shaw

    Managing Director

    She is also the Chairperson and Managing Director of Biocon. She is a first generation entrepreneur with more than 39 years’ experience in the field of biotechnology. She holds a Bachelor’s degree in Science (Zoology Hons.) from Bangalore University and a Master’s degree in Malting and Brewing from Ballarat College, Melbourne University. She has been awarded with several honorary degrees including Honorary Doctorate of Science from Ballarat University, National University of Ireland, Trinity College, Dublin and the University of Glasgow. She is the recipient of several national and global awards, the most noteworthy being the ‘PadmaShri’ and the ‘Padmabhushan’ Award in 1989 and 2005, respectively, conferred by the President of India. She was also conferred with ‘Ernst & Young Best Entrepreneur: Healthcare & Life Sciences Award (2002)’, ‘The Economic Times Business Woman of the Year Award (2004)’, ‘Nikkei Asia Prize for Regional Growth’ by Japan’s business daily, Nihon Keizai Shimbun, (2009) and the ‘Othmer Gold Medal’ by the U.S. based Chemical Heritage Foundation and ‘2014 Global Economy Prize’ by Germany’s Kiel Institute both in 2014. The prestigious Foreign Policy magazine has named her among the ‘100 Leading Global Thinkers of 2014’. She has also been named as one of the ‘100 Most Influential People in the World’ by TIME magazine in 2010, ‘25 Most Influential People in Biopharma’ by Fierce Biotech, Asia-Pacific's ‘Heroes of Philanthropy (2013)’ and ‘100 Most Powerful Women 2013 and 2015 by Forbes magazine and Asia's Power Businesswomen 2016 by Forbes Asia. She is also an Independent Director of the Board of Infosys, and is the Chairperson of the Indian Institute of Management, Bangalore. She is a part of the U.S. Pharmacopeial Convention (USP) Board of Trustees. She is a member of Karnataka's Vision Group on Biotechnology and currently chairs this forum. She has setup the Association of Biotech Led Enterprises (ABLE) in 2003 and was its first President. She serves on the National Advisory Council of the Government’s Department of Biotechnology. She is a member of the governing body of the Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India. She has been a Director of our Company since November 1993.

  • Jonathan Hunt

    Whole-time Director & CEO

    He holds a BA (Business Studies & Economics) degree from the University of Sheffield, United Kingdom and has done his MBA from Durham University, United Kingdom. He is responsible for leading Syngene's business operations as well as steering its investments in developing and strengthening its capabilities and capacities. He has more than 25 years of extensive experience in the global biopharmaceuticals industry. Prior to joining Syngene in January 2015, he worked with Astrazeneca for over a decade where he has held various leadership positions including President & Director of Astrazeneca, Austria and President & COO, Astrazeneca India. He is a director of our company from 1st May 2017.

  • John Shaw

    Non-Executive Director

    He holds a Master’s degree in Arts (Economic Hons.) in History and Political Economy from Glasgow University, United Kingdom. Prior to joining our Board, he had worked with Coats Viyella Plc. for 27 years in various capacities including finance and general administration and also served as Finance Director and Managing Director of Coats Viyella group companies in various locations around the world, before he came on the Board our Company. He has been a director of our Company since March 2000.

  • Catherine Rosenberg

    Non-Executive Director

    She holds a ‘Diplome d'Ingénieur’ from the Ecole Nationale Superieure des Telecommunications de Bretagne, an M.S. (Computer Science) from the University of California, a ‘Doctorat en Sciences’ from the Universite de Paris XI, is a Fellow Member of the Institute of Electrical and Electronics Engineers and a Fellow Member of the Canadian Academy of Engineering. She is a professor in electrical and computer engineering at the University of Waterloo. Since June 2010, she holds the Canada Research Chair in the Future Internet. She has been a Director of our Company since August 2000. She is a member of Nomination & Remuneration Committee & Corporate Social Responsibility Committee of the Company.

  • Rusell Walls

    Independent Director

    He is a Fellow Member of the Association of Chartered Certified Accountants, United Kingdom and brings to the Board his experience of more than 45 years in the field of finance. He possesses experience as director across a range of industries such as pharmaceuticals, textiles, transport and leisure. He is currently chairman of Aviva Life Holdings Limited and on the board of Mytrah Energy Limited, Aviva Italia Holdings SpA and Signet Jewellers Limited. He has been a Director of our Company since April 2011. He is a member of Audit & Risk Committee and Stakeholders Relationship Committee of the Company.

  • Paul Blackburn

    Independent Director

    He holds a Bachelor’s degree in Science (Management Sciences) from Warwick University, United Kingdom and a professional accounting qualification from Institute of Cost and Management Accountants, United Kingdom. He has over 38 years of experience in the field of finance. He is a senior finance executive with extensive emerging markets, corporate finance and change experience at GlaxoSmithKline, UK a global healthcare company. He has been a Director since August 2014. He is a Chairman of Audit & Risk Committee and a member of Stakeholders Relationship Committee of the Company.

  • Dr. Bala S. Manian

    Independent Director

    He holds a Bachelor’s degree in Science (Physics) from Loyola College, Chennai, a postgraduate level Diploma in Instrumentation from the Madras Institute of Technology, Chennai, a Masters’ degree in Optics from the University of Rochester and a Ph.D in Mechanical Engineering from Purdue University. He has 35 years of experience in the field of biomedical sciences. He holds over 40 patents in the field of physics, engineering and biomedical sciences. He has been awarded a Technical Academy Award by the Academy of Motion Picture Arts and Sciences in February 1999 for advances in digital cinematography. He has been a Director of our Company since June 2015. He is a Chairman of Nomination & Remuneration Committee & Corporate Social Responsibility Committee of the Company.

  • Suresh Talwar

    Independent Director

    He holds a Bachelor’s degree in Law from the Government Law College, Bombay (1961). He is a solicitor of the Incorporated Law Society, Mumbai. Mr. Talwar is enriched with experience across corporate law and other related matters. He has been the legal counsel to numerous Indian companies, multinational corporations as well as Indian and foreign banks. He served as partner at M/s. Crawford Bayley & Co and then founded Talwar Thakore & Associates, a law firm of repute. He is also on the Board of several leading companies such as Merck Limited,Sandvik Asia,Johnson & Johnson Limited amongst others. He also served on the Biocon Board for a period if twelve years from 2003 till July 2015. He is a Chairman of Stakeholders Relationship Committee and a member of Audit & Risk Committee, Nomination & Remuneration Committee & Corporate Social Responsibility Committee of the Company.

  • Dr. Vijay Kuchroo

    Independent Director

    He holds a Ph.D in Pathology from the University of Queensland, Brisbane (Australia). He is the Samuel L. Wasserstrom Professor of Neurology at the Harvard Medical School, Senior Scientist at Brigham & Women’s Hospital and Co-Director of the Center for Infection and Immunity, Brigham Research Institute, Boston. He possesses excellent experience in the field of immunology and has 25 patents to his credits. He has published over 325 research papers in immunology and serves on the scientific advisory Boards and works in advisory capacity to a number of big pharmaceutical companies including Pfizer, Novartis and Glaxo-Smith-Kline (GSK). He has founded 5 different biotech companies including CoStim Pharmaceuticals and Tempero Pharmaceuticals. He is also an Independent, Non-Executive Director on the Board of Biocon Limited. He is a member of Nomination & Remuneration Committee & Corporate Social Responsibility Committee of the Company.

  • Vinita Bali

    Independent Director

    Vinita Bali is a global business leader with extensive experience in leading large Companies both in India and overseas. She has worked with eminent multinationals like The Coca-Cola Company and Cadbury Schweppes PLC in a variety of Marketing, General Management and Chief Executive roles in the UK, Nigeria, South Africa, Latin America and the USA, in addition to Britannia Industries Ltd., in India. Effective April 2014, Vinita moved from a full-time operational role as MD & CEO in Britannia to pursue her wide-ranging interests in the corporate and development sectors, through a portfolio of roles and responsibilities. She is a Non-Executive Director on the Global Board of Smith & Nephew plc, Chairman of GAIN (Global Alliance for Improved Nutrition), a Swiss Foundation based in Geneva, and on the Advisory Board of Cornell University’s Department of Nutritional Science. She also served on the Global Board of Syngenta International AG from April 2012 to June 2017. In India, Vinita serves as a Non-Executive Director on the Boards of CRISIL Ltd, Titan Industries Ltd, and Kasturi & Sons Ltd; is a Member of the Board of Governors of Indian Institute of Management – Bangalore; and an Advisory Board Member of PwC. She brings a global and pragmatic perspective to strategy and operations, having lived and worked in 6 countries and 5 continents, with responsibility for global roles, in addition to regional ones. Vinita was among 27 global leaders appointed by the UN in 2012 to help improve maternal and child health as part of its SUN (Scaling up Nutrition) initiative and completed her term in 2016. She has been recognized in forums nationally and internationally and won several awards for her various contributions to the business.

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget